Search
for
Sort by
Research 241–270 of 1000+
- Treatment of persistent chemotherapy-induced hair loss (Alopecia) with human mesenchymal stromal cells exosome enriched extracellular vesicles: A case report
- The efficacy of scalp cooling in patients receiving chemotherapy for primary gynecologic cancers: a randomized controlled trial
- A case of alopecia areata after rabies vaccination: unreported adverse effect?
- Red LED light therapy for telogen effluvium in the course of long COVID in patients with and without androgenetic alopecia
- Hypoxia-Derived Mesenchymal Stem Cell Exosomes Downregulate CXCL12 and Upregulate IL-10 Expression in a Murine Model of Androgenic Alopecia
- Alopecia induced by lopinavir plus ritonavir therapy in an HIV patient.
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Management of long COVID-19 in children and adolescents: from diagnosis to therapeutically approaches
- Acceptance of COVID-19 Vaccine Booster Doses Using the Health Belief Model: A Cross-Sectional Study in Low-Middle- and High-Income Countries of the East Mediterranean Region
- The immune response to COVID‐19: Does sex matter?
- Upper gastrointestinal bleeding during the COVID-19 pandemic; particularities of diagnosis and therapy
- Use of Antiandrogens as Therapeutic Agents in COVID-19 Patients
- Post severe COVID-19 infection lung damages study. The experience of early three months multidisciplinary follow-up
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- Long- COVID and general health status in hospitalized COVID-19 survivors
- Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
- A comprehensive review of etiology, pathophysiologyepidemiology, and management of hair loss and its correlation with COVID-19
- Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia
- Association between Mesenchymal Stem Cells and COVID-19 Therapy: Systematic Review and Current Trends
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19.
- Insights into disparities observed with COVID‐19
- What’s Sex Got to Do With COVID-19? Gender-Based Differences in the Host Immune Response to Coronaviruses
- Polycystic ovary syndrome (PCOS) and COVID-19: an overlooked female patient population at potentially higher risk during the COVID-19 pandemic
- Final Results of a Randomized, Placebo-Controlled, Two-Arm, Parallel Clinical Trial of Proxalutamide for Hospitalized COVID-19 Patients: A Multiregional, Joint Analysis of the Proxa-Rescue AndroCoV Trial
- Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19
- Rare and common manifestations of COVID‐19 in children
- Perspective Chapter: Repurposing Natural Products to Target COVID-19 – Molecular Targets and New Avenues for Drug Discovery
- Correlations between soluble receptor for advanced glycation end products and heme oxogenase-1 in post-COVID-19 patients with telogen effluvium
- Asymptomatic SARS-COV2 Infection or COVID-19 vaccination effect for severe multisystem inflammatory syndrome in a 6-year-old girl: case report and review of the literature